Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Liabilities and Shareholders Equity came in at $681.9 million in Q2 2026, up 7.44% on a YoY basis from $634.7 million in Q2 2025, and up 1.07% quarter-over-quarter from $674.7 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $681.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 7.44% year-over-year to $681.9 million; the trailing twelve-month figure through Jun 2026 stood at $2.7 billion (up 4.7% YoY), and the FY2025 full-year result was $655.1 million, up 4.15% from the prior year.
- Liabilities and Shareholders Equity rose to $681.9 million in Q2 2026 per UFPT's latest filing, from $674.7 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $681.9 million in Q2 2026 and bottomed at $363.3 million in Q1 2022.
- Historically, Liabilities and Shareholders Equity has averaged $508.7 million across 5 years, with a median of $415.0 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity jumped 81.81% in 2022, then gained 0.74% in 2023.
- Over 5 years, Liabilities and Shareholders Equity stood at $378.2 million in 2022, then climbed by 6.86% to $404.1 million in 2023, then jumped by 55.64% to $629.0 million in 2024, then climbed by 4.15% to $655.1 million in 2025, then climbed by 4.1% to $681.9 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $681.9 million, $674.7 million, and $655.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 681.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 681.91 Mn |
| Mar 31, 2026 | 674.68 Mn |
| Dec 31, 2025 | 655.08 Mn |
| Sep 30, 2025 | 652.82 Mn |
| Jun 30, 2025 | 634.66 Mn |
| Mar 31, 2025 | 642.64 Mn |
| Dec 31, 2024 | 629.00 Mn |
| Sep 30, 2024 | 638.51 Mn |
| Jun 30, 2024 | 422.40 Mn |
| Mar 31, 2024 | 407.68 Mn |
| Dec 31, 2023 | 404.14 Mn |
| Sep 30, 2023 | 399.81 Mn |
| Jun 30, 2023 | 397.99 Mn |
| Mar 31, 2023 | 390.78 Mn |
| Dec 31, 2022 | 378.19 Mn |
| Sep 30, 2022 | 388.32 Mn |
| Jun 30, 2022 | 395.05 Mn |
| Mar 31, 2022 | 363.35 Mn |
| Dec 31, 2021 | 334.13 Mn |
| Sep 30, 2021 | 220.69 Mn |